Oxford BioMedica PLC - Asset Resilience Ratio

Latest as of June 2023: 0.01%

Oxford BioMedica PLC (OXB) has an Asset Resilience Ratio of 0.01% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Oxford BioMedica PLC (OXB) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

GBX31.00K

≈ $3.77 USD Cash + Short-term Investments

Total Assets

GBX401.06 Million

≈ $48.80K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2022)

This chart shows how Oxford BioMedica PLC's Asset Resilience Ratio has changed over time. See net assets of Oxford BioMedica PLC for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Oxford BioMedica PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Oxford BioMedica PLC market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX31.00K	0.01%
Total Liquid Assets	GBX31.00K	0.01%

Asset Resilience Insights

Limited Liquidity: Oxford BioMedica PLC maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Oxford BioMedica PLC Industry Peers by Asset Resilience Ratio

Compare Oxford BioMedica PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Oxford BioMedica PLC (2003–2022)

The table below shows the annual Asset Resilience Ratio data for Oxford BioMedica PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	0.00%	GBX23.00K ≈ $2.80	GBX460.18 Million ≈ $55.99K	-0.03pp
2021-12-31	0.03%	GBX74.00K ≈ $9.00	GBX237.23 Million ≈ $28.86K	-0.10pp
2020-12-31	0.13%	GBX239.00K ≈ $29.08	GBX183.93 Million ≈ $22.38K	-2.08pp
2019-12-31	2.21%	GBX2.72 Million ≈ $330.82	GBX122.93 Million ≈ $14.96K	-18.69pp
2012-12-31	20.90%	GBX5.11 Million ≈ $621.13	GBX24.42 Million ≈ $2.97K	-7.84pp
2011-12-31	28.74%	GBX7.50 Million ≈ $912.53	GBX26.09 Million ≈ $3.18K	+6.89pp
2010-12-31	21.85%	GBX5.60 Million ≈ $681.72	GBX25.64 Million ≈ $3.12K	-20.25pp
2009-12-31	42.09%	GBX18.50 Million ≈ $2.25K	GBX43.95 Million ≈ $5.35K	+10.21pp
2008-12-31	31.89%	GBX13.75 Million ≈ $1.67K	GBX43.12 Million ≈ $5.25K	-12.56pp
2007-12-31	44.45%	GBX27.18 Million ≈ $3.31K	GBX61.16 Million ≈ $7.44K	-13.24pp
2006-12-31	57.68%	GBX20.50 Million ≈ $2.49K	GBX35.54 Million ≈ $4.32K	+9.96pp
2005-12-31	47.72%	GBX23.50 Million ≈ $2.86K	GBX49.24 Million ≈ $5.99K	-13.50pp
2004-12-31	61.22%	GBX17.50 Million ≈ $2.13K	GBX28.58 Million ≈ $3.48K	-25.12pp
2003-12-31	86.34%	GBX31.70 Million ≈ $3.86K	GBX36.71 Million ≈ $4.47K	--

pp = percentage points

About Oxford BioMedica PLC

LSE:OXB UK Biotechnology

Market Cap

$8.71 Million

GBX71.61 Billion GBX

Market Cap Rank

#27217 Global

#369 in UK

Share Price

GBX593.00

Change (1 day)

-1.17%

52-Week Range

GBX277.00 - GBX913.00

All Time High

GBX1634.00